The EB-StaR study was published at European Urology today! ✅ It is a randomised study comparing en bloc resection of bladder tumour (ERBT) and conventional transurethral resection of bladder tumour (TURBT) in patients with bladder tumour(s) <= 3 cm in size. 🏥 #UroSoMe (1/n)

CME Symposium 45th @SIU_Urology congress Grateful to distinguished faculty @pcvblack @jteoh_hk @paolo_gontero @ParamMariappan @VikramNarayan for their outstanding insights on advancing NMIBC management. #SIU2025Edinburgh #UroOncology #BladderCancer #NMIBC #Parientcare

Heres a little behind the scenes action of my phonk beats

Starting in 30 min: #SIU2025Edinburgh luncheon symposium: Advancing NMIBC Management: From Clinical Evidence to Daily Practice. Join Dr Peter Black, Prof Jeremy Teoh, Prof Paolo Gontero, Prof Param Mariappan and Dr Vikram Narayan in Sidlaw Auditorium, L3, EICC or online on the

Honored to debate TURBT vs. En Bloc Resection with @jteoh_hk at #B2BGUCancersTriad during @SIU_urology Congress #SIU2025Edinburgh 🎤💥 Proud to advance innovation, quality, and safety in #BladderCancer care. Grateful to share this global stage 🌍 @UTMBUrology @UTMBPresident

🤖The true power of #AI in medicine lies in partnership — augmenting human expertise, improving precision, and expanding access to quality care #IMHO the future of healthcare is intelligent and inclusive What a treat connect, exchange ideas and the enthusiasm for our discipline

Everyone starts somewhere. The person with $100,000 invested today once had their first $100. The difference? They started. Your turn. Let Mamo grow your @USDC, always earning the best rate and auto-compounding returns without needing to lift a finger.

Excellent meeting in CUHK Symposium 2025. New collaborations and work to be done in spreading the love for academia in Urology. Thank you @jteoh_hk @steffiyuen for including me and letting me share some to our colleagues. Awesome 2 days will definitely comeback and recommend

omg as his little 🪭fan, I am very honored & 🌟struck to be recognized by Prof @Albert0Briganti for our latest endourology work in @EUplatinum !! Let’s keep up the high quality work and make a difference 💪🏻! #ARISTA @CUHKMedicine @zeng_guohua #weizhu @CHAIcaMD @migokce

Wonderful short visit #CUHK 🙏 @steffiyuen @jteoh_hk for the invitation 🙏👍 #ARISTA, Urology Symposium & hospital. Leaving with renewed ideas & exchange with like minded friends 🙌 paving forward for collaboration & continued friendship👍 @asiaendouro @PEARLSendouro @Uroweb

👏 Congratulations to @jteoh_hk on his inspiring presentation at the Urology Symposium! 🌟 So great to see home-grown innovation from @CUHKofficial pushing the boundaries of surgical robotics. 🚀 A true milestone for HK & Asian innovation! 🇭🇰🤖

✦ Free 3D background tool trial & more rewards! "ABLUR Early Creators Club" Season 2 is live! Illustration, webcomics, cartoons... ABLUR helps you create style-perfect backgrounds for any kind of digital drawing. Faster, smarter, better art.

Thrilled to be at the #Urologysymposium in Hong Kong lead by @jteoh_hk , sharing insights on how #AI is transforming healthcare and shaping the future of medicine! 🤖🌏 #Urology #HealthTech @USC_Urology @Urology_AI @uroAI_news

Humbled to present at this amazing conference organized by @jteoh_hk with @Albert0Briganti @BenjaminPradere @alexandracomte @amassonlecomte @jleow @Cacciamani_MD @DocGauhar Title of talk not chosen by me!

🎤 @jteoh_hk Kicking off the ARISTA Programme — The Asian Rising Star Programme for Research Skills Training and Academic Leadership! Exciting discussions ahead at the Urology Symposium as we empower the next generation of academic leaders in urology. 💡🔬@CUHKMedicine

Outstanding talk by the one and only one @Albert0Briganti @EUplatinum Impact Factor ≠ True Journal Impact Remember: ✅ A few popular papers can skew the IF ✅ Reviews & self-citations can inflate it ✅ It reflects short-term (2-year) citations only ✅ It says nothing about

Did you know ISPs can sell your browsing related data to advertisers? It's essential to clear your browsing activity regularly and protect it with NordVPN.

🔬 Insightful talk by @jteoh_hk (@CUHK) on “Running a FIH Trial: How we did it?” at the ARISTA Programme — sharing first-hand experience on translating innovation from bench to bedside. 🚀 #UrologySymposium #ARISTA #ClinicalResearch #FIH #MedicalInnovation

🎯@BenjaminPradere (@UROSUD) sharing insights on “How to Conduct a High-Quality Randomized Trial: A Practical Guide” at the ARISTA Program @CUHKMedicine 🔑Key takeaways: • Design trials with clear, answerable questions • Ensure rigorous methodology and transparency •

🌟 Inspiring talk by @siadaneshmand @USC_Urology at the Urology Symposium (ARISTA Programme) — “Becoming a Pioneer in Uro-oncology: What Have I Learnt Through the Process?” 💬 Highlight: Challenging the Status Quo — promoting evidence-based innovation, questioning tradition for

🌍 Dr. @DocGauhar emphasized the value of international collaboration in urology research — unlocking opportunities to: 🔹 Access larger and more diverse patient cohorts 🔹 Pool expertise and perspectives across borders 🔹 Standardize care through evidence-based guidelines 🔹

That’s a wrap on Q3. Lots of exciting things happening at @FlyArcher, beginning with our acquisition of the Hawthorne Airport, which is strategically located in the heart of Los Angeles just miles from LAX, SoFi Stadium, downtown Los Angeles and Long Beach. We’re planting the

Another fantastic talk by @AndreaNecchi #ESMO25 👉At primary analysis, intravesical TAR-200 + cetrelimab showed high pCR, pOR and 1-y RFS in MIBC #bladdercancer 👉Clearance of urinary tumor DNA portends ⬆️ rPFS👇@OncoAlert @OncBrothers @BladderCancerUS

At @myESMO #esmo2025 Berlin, I had the privilege to present the #ALBAN trial (GETUG–AFU 37), an academic phase III study led by @AFUrologie & @GETUG_Unicancer @LaCarine1 together with my outstanding co-PI @y_loriot ,co-investigators @PignotG @champiatMD @PrRomainMATHIEU

Deeply grateful to God, my family, and everyone who believes in science with purpose. Honored to receive the First Place Frank A. Hughes Award at @CAUrologia — This recognition belongs to my team and my patients—the true reason behind every effort. Dedicated to my mentor, Dr.

Our latest @EUOncology consensus from the International Bladder Cancer Group (IBCG) provides updated recommendations for Intermediate-Risk NMIBC - a group representing ~50–60% of all NMIBC yet often inconsistently managed. We define IR-NMIBC precisely and outline evidence based